Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Front Public Health ; 9: 712584, 2021.
Article in English | MEDLINE | ID: mdl-34676192

ABSTRACT

Background: Organ shortage is still a world-wide problem, resulting in long waiting lists for kidney, liver, and heart transplant candidates across many transplant centers globally. This has resulted in the move toward presumed consent to increase deceased organ donation rates. However, there remains a paucity of literature on public attitude and barriers regarding the opt-out system, with existing studies limited to Western nations. Therefore, this study aimed to understand public sentiment and different barriers toward organ donation from the perspective of Singapore, a highly diverse and multiethnic Asian society. Methods: A cross-sectional community semi-structured interview was conducted in a public housing estate in Singapore. Pilot test was undertaken before participants were interviewed face-to-face by trained personnel. All statistical evaluations were conducted using Stata. The χ2-test compared subgroups based on patient characteristics while multivariable logistic regression identified predictors of willingness to donate/ assent. Effect estimates were quantified using odds ratio (OR). Findings: Out of 799 individuals, 85% were agreeable to organ donation after death and 81% were willing to assent to donations of family members' organs, which declined by 16% (p < 0.001) after a clinical scenario was presented. Demographic factors including ethnicity, education, marital, and employment status affected willingness to donate and assent. Knowledge correlated significantly with willingness to donate and assent. In particular, knowledge regarding brain death irreversibility had the strongest correlation (AOR 2.15; 95% CI 1.60-2.89). Conclusions: Organ donation rates remain low albeit presumed consent legislation, due to patient-level barriers, including but not limited to knowledge gaps, cultural values, religious backgrounds, and emotional impact at relatives' death. To effectively boost donor rates, it is crucial for policy makers to invest in public education and improve transplant provisions and family protocols.


Subject(s)
Presumed Consent , Tissue and Organ Procurement , Cross-Sectional Studies , Humans , Perception , Tissue Donors
2.
Surg Oncol ; 20(4): e207-14, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21824763

ABSTRACT

Hepatocellular carcinoma (HCC) directly invading the gastrointestinal (GI) organs is rare and is associated with poor survival outcome. We report two patients with good long-term outcome following resection of HCC that invaded the stomach and duodenum, respectively. A literature review was conducted to elucidate the course of patients with this pathology. Two cases (57-year-old and 72-year-old males) with enlarged hepatic tumors directly invading the stomach and duodenum underwent hepatectomies with en-bloc resection of the involved organs. Both patients are still alive at 80 and 68 months following the surgery. Our literature review showed that most of the patients with this pathology have manifested, and died of persistent GI bleeding. Patients who were treated surgically had a statistically significant longer survival than those who were treated with non-surgical palliative treatments (P < 0.001). In addition, patients who were treated with surgery with curative intent tend to have a longer survival times than those who were treated with surgery to palliate the bleeding but the difference was not statistically significant (P < 0.174). Removing the tumor completely could significantly prolong the survival of patients with HCC invading the GI tract.


Subject(s)
Carcinoma, Hepatocellular/mortality , Gastrointestinal Neoplasms/mortality , Hepatectomy , Liver Neoplasms/mortality , Aged , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/surgery , Gastrointestinal Hemorrhage , Gastrointestinal Neoplasms/secondary , Gastrointestinal Neoplasms/surgery , Humans , Liver Neoplasms/pathology , Liver Neoplasms/surgery , Male , Middle Aged , Review Literature as Topic , Survival Rate
3.
Ann Surg Oncol ; 16(7): 1832-42, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19365625

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the long-term outcomes of liver resection for hepatocellular carcinoma (HCC). METHODS: Between January 1993 and December 2002, a total of 473 patients underwent hepatectomy for HCC at a medical center in Taiwan. Clinicopathological and surgical characteristics were studied to identify prognostic factors influencing survival. RESULTS: There were 379 men (80.1%) with mean +/- standard deviation age of 53.1 +/- 13.1 years. The etiology of HCC was hepatitis B (n = 277), hepatitis C (n = 90), coinfection with hepatitis B and C (n = 47), and non-B or C hepatitis (n = 50). The blood loss was 282.3 +/- 370.5 ml, and 411 patients (86.9%) did not require perioperative blood transfusion. On univariate analysis, the statistically significant independent factors for disease-free survival were alfa-fetoprotein (AFP) levels of >400 ng/ml, indocyanine green retention of >10%, Pringle maneuver, blood transfusion, tumor diameter >5 cm, bilateral tumors, microvascular invasion, adjacent tissue invasion, daughter nodules and cirrhotic liver. The univariate factors influencing overall survival were similar to those influencing disease-free survival except for AFP. Independent factors that statistically significantly affected overall survival on multivariate analysis included Pringle maneuver, blood transfusion, tumor diameter >3 cm, microvascular invasion, daughter nodules, and liver cirrhosis. The 1-, 5-, and 10-year disease-free survival were 75.3, 43.3, and 22.3%, respectively. The 1-, 5-, and 10-year overall survival were 86.7, 55, and 33.7%, respectively. CONCLUSIONS: AFP, indocyanine green retention of >10%, blood transfusion, Pringle maneuver, tumor diameter of >3 cm, bilateral tumors, microvascular invasion, adjacent tissue invasion, daughter nodules, and liver cirrhosis influence survival.


Subject(s)
Carcinoma, Hepatocellular/surgery , Hepatectomy/mortality , Liver Neoplasms/surgery , Adult , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/virology , Disease-Free Survival , Female , Humans , Liver Neoplasms/mortality , Liver Neoplasms/virology , Male , Middle Aged , Neoplasm Staging , Prognosis , Survival Analysis , Treatment Outcome
4.
Surgery ; 143(5): 686-90, 2008 May.
Article in English | MEDLINE | ID: mdl-18436017

ABSTRACT

BACKGROUND: Alternatives to the hepatic artery (HA) are needed in liver transplantation when the native HA cannot be used or when HA complications develop. We describe the indications, technique, and results of our experience using the right gastroepiploic (RGEA) and left gastric (LGA) arteries as alternative HA inflow in adult-to-adult living donor liver transplantation (LDLT). METHODS: From January 1999 to June 2006, 130 patients underwent primary adult-to-adult LDLT (excluding dual graft transplantations). Seven patients required an HA alternative due to hepatic arterial complication. The recipient and graft demographic characteristics, arterial complication, and alternate arteries used were analyzed. RESULTS: One hundred twenty-six (126) patients received right lobe liver grafts and four received left lobe grafts. Four patients required an HA alternative due to intimal dissection of the recipient HA found during primary transplant, and three patients had salvage during re-operation for HA thrombosis. The RGEA was used in five patients and LGA in two patients. Four patients had no further complication on long-term follow-up. One patient had biliary stricture requiring intervention, and two patients had bile leak. One bile leak recipient had his bile leakage resolved spontaneously without sequelae. One patient with two graft HA reconstructed had graft loss due to bile leak and sepsis following re-operation for HA occlusion. CONCLUSION: The RGEA and LGA can be successfully used as alternative HA inflow for hepatic arterial revascularization with good results in LDLT. The method has the advantage of single anastomosis compared to an interposition graft.


Subject(s)
Arterial Occlusive Diseases/surgery , Epigastric Arteries/transplantation , Hepatic Artery/surgery , Liver Transplantation/adverse effects , Adult , Female , Humans , Living Donors , Male , Middle Aged
5.
Liver Transpl ; 13(6): 848-52, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17539004

ABSTRACT

Liver transplantation (LT) may be indicated in glycogen storage disorders (GSD) when medical treatment fails to control the metabolic problems or when hepatic adenomas develop. We present our institutional experience with living donor LT (LDLT) for children with GSD. A total of 244 patients underwent primary LDLT at our institution from June 1994 to December 2005. A total of 12 (5%) children (8 female and 4 male) were afflicted with GSD and were not responsive to medical treatment. Nine patients had GSD type I and 3 had GSD type III. The median age at the time of transplantation was 7.27 yr (range, 2.4-15.7). All patients presented with metabolic abnormalities, including hypoglycemia, and lactic acidosis. In addition, 4 patients presented with growth retardation. A total of 11 patients received left lobe grafts and 1 received a right lobe graft. The mean graft-to-recipient weight ratio was 1.25 (range, 0.89-1.61). Two patients had hepatic vein stenoses that were treated by balloon dilatation; 1 patient had bile leak, which settled spontaneously. The overall surgical morbidity rate was 25%. Three patients had hepatic adenomas in the explanted liver. There was a single mortality at 2 months posttransplantation due to acute pancreatitis and sepsis. The mean follow up was 47.45 months. The metabolic abnormalities were corrected and renal function remained normal. In patients with growth retardation, catch-up growth was achieved posttransplantation. In conclusion, LDLT is a viable option to restore normal metabolic balance in patients with GSD when medical treatment fails. Long-term follow-up after LT for GSD shows excellent graft and patient survival.


Subject(s)
Glycogen Storage Disease Type III/surgery , Glycogen Storage Disease Type I/surgery , Liver Transplantation , Living Donors , Postoperative Complications , Adolescent , Adult , Child , Child, Preschool , Female , Follow-Up Studies , Glycogen Storage Disease Type I/physiopathology , Glycogen Storage Disease Type III/physiopathology , Growth Disorders/etiology , Growth Disorders/therapy , Humans , Male , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...